[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @Turb0888 Turbo_Trades Turbo_Trades posts on X about $mdcx, acquisition, $297m, $65m the most. They currently have XXXXX followers and X posts still getting attention that total X engagements in the last XX hours. ### Engagements: undefined [#](/creator/twitter::1262908059422265346/interactions)  - X Week XX -XX% - X Month XXXXX -XX% - X Months XXXXXX +20% - X Year XXXXXXX +11% ### Mentions: undefined [#](/creator/twitter::1262908059422265346/posts_active)  - X Week X -XX% - X Month XX -XX% - X Months XXX -XXXX% - X Year XXX +137% ### Followers: XXXXX [#](/creator/twitter::1262908059422265346/followers)  - X Week XXXXX +0.09% - X Month XXXXX +0.09% - X Months XXXXX +1.30% - X Year XXXXX +2.10% ### CreatorRank: undefined [#](/creator/twitter::1262908059422265346/influencer_rank)  ### Social Influence **Social category influence** [finance](/list/finance) XXXXX% **Social topic influence** [$mdcx](/topic/$mdcx) 66.67%, [acquisition](/topic/acquisition) 66.67%, [$297m](/topic/$297m) 33.33%, [$65m](/topic/$65m) 33.33%, [$6b](/topic/$6b) 33.33%, [health](/topic/health) 33.33%, [summary](/topic/summary) 33.33%, [target](/topic/target) 33.33%, [targets](/topic/targets) XXXXX% ### Top Social Posts Top posts by engagements in the last XX hours "$MDCX quick summary of the merger from Yesterday ☑Purchase Price:$2.97M in cash + 1.6M shares ☑Potential Upside:Up to US$65M in contingent payments ☑Market Opportunity:$6B total across two indications ☑Clinical Progress: FDA-approved Phase 2b trials ready to launch ☑Leadership Boost: Industry veteran added to board" [X Link](https://x.com/Turb0888/status/1963285580025933843) 2025-09-03T16:58Z 7995 followers, XXX engagements "$MDCX According to MarketBeat the consensus average price target is $XXXXX based on research reports from four analysts. The targets range from a high of $XXXXX to a low of $XXXXX Most recent corporate developments and clinical trial progress: ☑Acquisition of Antev Limited: Medicus recently completed the acquisition of Antev gaining its clinical-stage drug Teverelix which targets a potential $X billion market for prostate cancer and acute urinary retention. ☑Clinical trial progress: The company is advancing its Phase X clinical program for D-MNA a skin patch for non-melanoma skin cancer." [X Link](https://x.com/Turb0888/status/1963315938528317479) 2025-09-03T18:59Z 7995 followers, XXX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@Turb0888 Turbo_TradesTurbo_Trades posts on X about $mdcx, acquisition, $297m, $65m the most. They currently have XXXXX followers and X posts still getting attention that total X engagements in the last XX hours.
Social category influence finance XXXXX%
Social topic influence $mdcx 66.67%, acquisition 66.67%, $297m 33.33%, $65m 33.33%, $6b 33.33%, health 33.33%, summary 33.33%, target 33.33%, targets XXXXX%
Top posts by engagements in the last XX hours
"$MDCX quick summary of the merger from Yesterday ☑Purchase Price:$2.97M in cash + 1.6M shares ☑Potential Upside:Up to US$65M in contingent payments ☑Market Opportunity:$6B total across two indications ☑Clinical Progress: FDA-approved Phase 2b trials ready to launch ☑Leadership Boost: Industry veteran added to board"
X Link 2025-09-03T16:58Z 7995 followers, XXX engagements
"$MDCX According to MarketBeat the consensus average price target is $XXXXX based on research reports from four analysts. The targets range from a high of $XXXXX to a low of $XXXXX Most recent corporate developments and clinical trial progress: ☑Acquisition of Antev Limited: Medicus recently completed the acquisition of Antev gaining its clinical-stage drug Teverelix which targets a potential $X billion market for prostate cancer and acute urinary retention. ☑Clinical trial progress: The company is advancing its Phase X clinical program for D-MNA a skin patch for non-melanoma skin cancer."
X Link 2025-09-03T18:59Z 7995 followers, XXX engagements
/creator/twitter::Turb0888